ePT--the Electronic Newsletter of Pharmaceutical Technology, Jan 3, 2013 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
ePT--the Electronic Newsletter of Pharmaceutical Technology, Jan 3, 2013
News
Mylan Recalls Painkiller Pills due to Risk of Higher Dosage
By Adeline Siew, PhD
Mylan issued a voluntary recall of three lots of the painkiller tablets hydrocodone bitartrate and acetaminophen.
GSK Partners with Vodafone for Vaccinations
By Stephanie Sutton
GlaxoSmithKline has formed a partnership with Vodafone to use mobile technology to help vaccinate more children against common infectious diseases in Africa.
FDA Approvals of NMEs and BLAs Increased in 2012
By Patricia Van Arnum
Additional approvals in December have helped to outpace a recent high set in 2011.
BASF Extends Offer Period to Acquire Pronova BioPharma
By Adeline Siew, PhD
BASF extended its offer period to acquire Pronova BioPharma, a producer of omega-3 fatty acids.
Week of December 31, 2012: Mylan, Orion Enter Into Comtan Settlement Agreement; Takeda, Amylin Terminate Agreement to Codevelop and Commercialize Compounds for Obesity; and More
Mylan, Orion Enter Into Comtan Settlement Agreement; Takeda, Amylin Termination Agreement to Codevelop and Commercialize Compounds for Obesity; and More.

ADVERTISEMENT
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
20%
To all process for new products only
15%
To select process for new products only
24%
To select processes for both new and legacy products
20%
Do not use QbD
22%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Featured Jobs

More Jobs
Click here